ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

QGEN Qiagen NV

40.00
0.53 (1.34%)
Apr 19 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,107,980
Bid Price
Ask Price
News -
Day High 40.14

Low
35.8135

52 Week Range

High
49.1739

Day Low 39.64
Company Name Stock Ticker Symbol Market Type
Qiagen NV QGEN NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.53 1.34% 40.00 18:56:23
Open Price Low Price High Price Close Price Prev Close
39.64 39.64 40.14 40.00 39.47
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
14,497 1,107,980 $ 39.96 $ 44,278,262 - 35.8135 - 49.1739
Last Trade Time Type Quantity Stock Price Currency
19:00:00 144,986 $ 40.00 USD

Qiagen NV (QGEN) Options Flow Summary

Overall Flow

Bullish

Net Premium

80k

Calls / Puts

100.00%

Buys / Sells

0.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

Qiagen NV Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
9.13B 228.20M - 1.97B 341.3M 1.50 26.75
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Qiagen NV News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No QGEN Message Board. Create One! See More Posts on QGEN Message Board See More Message Board Posts

Historical QGEN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week40.7840.9339.0339.54735,609-0.78-1.91%
1 Month43.7943.8539.0341.52880,863-3.79-8.65%
3 Months45.751345.947239.0343.151,016,168-5.75-12.57%
6 Months38.906247.292535.813542.801,200,6371.092.81%
1 Year46.637949.173935.813544.061,161,521-6.64-14.23%
3 Years53.998559.792235.813547.45938,691-14.00-25.92%
5 Years39.462960.823125.566344.631,166,4660.537151.36%

Qiagen NV Description

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (45% of 2021 sales), followed by EMEA (36%) and Asia-Pacific (19%).

Your Recent History

Delayed Upgrade Clock